Authors: Nunez-Castilla J, Stebliankin V, Baral P, Balbin CA, Sobhan M, Cickovski T et al. PMID: 35891400 PMCID: PMC9318917 DOI: 10.3390/v14071415 Abstract Molecular mimicry between viral antigens and host proteins can produce cross-reacting antibodies leading to autoimmunity. The coronavirus SARS-CoV-2 causes COVID-19, a disease curiously resulting in varied symptoms and outcomes, ranging from asymptomatic to [...]

Authors: Callaway E doi: https://doi.org/10.1038/d41586-022-01730-y Abstract The lineages’ rise seems to stem from their ability to infect people who were immune to earlier forms of Omicron and other variants. Keywords: vaccines, virology, SARS-CoV2 Source: https://www.nature.com/articles/d41586-022-01730-y Archive: https://archive.is/M7EN7

Authors: Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Lu S et al. doi: https://doi.org/10.1101/2022.06.21.22276660 Abstract Epstein-Barr virus (EBV) reactivation has been proposed as a driver of Long COVID (LC), but studies in well- characterized post-acute COVID-19 cohorts of individuals with and without Long COVID symptoms over a time course consistent with current [...]

Authors: Gallardo-Zapata J, Maldonado-Bernal C PMID: 35733383 PMCID: PMC9389049 DOI: 10.1177/17534259221077750 Abstract At the end of 2019, an outbreak of a severe respiratory disease occurred in Wuhan China, and an increase in cases of unknown pneumonia was alerted. In January 2020, a new coronavirus named SARS-CoV-2 was identified as the cause. The virus spreads primarily [...]

Authors: Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J PMID: 35731894 PMCID: PMC9258748 DOI: 10.1056/NEJMc2206576 Abstract In recent months, multiple lineages of the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged,1 with subvariants BA.1 and BA.2 showing substantial escape from neutralizing antibodies.2-5 Subvariant BA.2.12.1 is now the dominant [...]

Authors: Muller C, Karl N, Ziebuhr J, Pleschka S PMID: 35805887 PMCID: PMC9266999 doi: 10.3390/ijms23136880 Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the coronavirus disease-19 (COVID-19) is still challenging healthcare systems and societies worldwide. While vaccines are available, therapeutic strategies are developing and need to be adapted to each patient. Many clinical [...]

Auhtors: Rawat SG, Tiwari RK, Jaiswara PK, Gupta VK, Sonker P, Vishvakarma NK, et al. PMID: 35725975 DOI: 10.1007/s10495-022-01741-0 Abstract Cyclic nucleotide phosphodiesterase 5 (PDE5) has been recently identified to play a crucial role in the progression of many cancers. PDE5 promotes tumorigenesis by dysregulating various cellular processes such as proliferation, apoptosis, angiogenesis, and invasion [...]

Authors: Carpene G, Negrini D, Henry BM, Montagnana L, Lippi G PMID: 35704707 DOI: 10.1515/dx-2022-0042 Abstract Objectives: Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disorder characterized by a sustained prothrombotic state. Since homocysteine is a potential biomarker of thrombotic diseases, the aim of this article is to provide an updated overview on the possible [...]

Authors: Perez JC, Moret-Chalmin C, Montagnier L DOI: 10.5281/zenodo.6641999 Abstract "Resubmitted preprint withdrawn after 132 000 reads on RESEARCHGATE" We highlight the presence of a Prion region in the different Spike proteins of the original SARS-CoV2 virus as well as of all its successive variants but also of all the “vaccines” built on this same [...]

Auhtors: Goubran H, Stakiw J, Seghatchian J, Ragab G, Burnouf T PMID: 35753906 PMCID: PMC9192107 DOI: 10.1016/j.transci.2022.103488 Abstract The COVID-19 pandemic caused by the SARS-CoV-2 virus has significantly disrupted and burdened the diagnostic workup and delivery of care, including transfusion, to cancer patients across the globe. Furthermore, cancer patients suffering from solid tumors or hematologic [...]